Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
The Testicular Iron Shuttle: A “Nurse” Function of the Sertoli Cells
1994
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Angiogenic Oligosaccharides of Hyaluronan Induce Multiple Signaling Pathways Affecting Vascular Endothelial Cell Mitogenic and Wound Healing Responses
2002
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Estrogen and progesterone receptors in cytology: A comprehensive review
1992
Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma
2016
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 Standout
Cancer to bone: a fatal attraction
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
The Nottingham prognostic index in primary breast cancer
1992
Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
2010
Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents
1997
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer
1995
Prognostic factors in early breast carcinoma
1994
Immunocytochemical Analysis of Estrogen Receptors in Human Breast Carcinomas
1990
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries
2009 StandoutNobel
Pathological prognostic factors in breast cancer
1999 Standout
Tissue microarrays for high-throughput molecular profiling of tumor specimens
1998 Standout
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer
1993
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Hyaluronidase gene profiling and role of HYAL‐1 overexpression in an orthotopic model of prostate cancer
2001
Manipulation of Hyaluronan Synthase Expression in Prostate Adenocarcinoma Cells Alters Pericellular Matrix Retention and Adhesion to Bone Marrow Endothelial Cells
2002
Survival analysis in natural history studies of disease
1989
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Biomedical applications of collagen
2001 Standout
Cross-linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancer
2001
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Dermal Lymphatic Emboli in Inflammatory and Noninflammatory Breast Cancer: A French-Tunisian Joint Study in 337 Patients
2005
Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: Comparison between invasive and non‐invasive areas
1992
Calculating the sample size required for developing a clinical prediction model
2020 Standout
Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death
1994 Standout
Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution
2010
Organizing the cell cortex: the role of ERM proteins
2010 Standout
Mechanisms of Bone Metastasis
2004 Standout
The clinical use of bone resorption markers in patients with malignant bone disease
2002
Fibroblasts in cancer
2006 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
Breast cancer metastasis: markers and models
2005 Standout
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
2002
Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
2008
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival
1990
Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid
2005
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
1998 Standout
Prospective Evaluation of the Peptide-Bound Collagen Type I Cross-Links N-Telopeptide and C-Telopeptide in Predicting Bone Metastases Status
2002
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
2007 StandoutScience
Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
2006
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
2006
The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.
1987
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
1996
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer
2018
Mitoxantrone: A New Anticancer Drug with Significant Clinical Activity
1986
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The impact of extracellular matrix on the chemoresistance of solid tumors – experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy
1998
The renal toxicity of cancer chemotherapeutic agents
1982
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
2000
A systematic review of the role of bisphosphonates in metastatic disease
2004
Cisplatin
1984 Standout
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Works of P Bastit being referenced
Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck
1992
Biochemical exploration of azoospermia: interest of the seminal transferrin assay
1989
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy
1997
Serum hyaluronan (hyaluronic acid) in breast cancer patients
1990
The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients
1993
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer
1989
Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion
1999
A prognostic score in histological node negative breast cancer
1990
Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers
2001
Prognostic value of estrogen and progesterone receptors in operable breast cancer: Results of a univariate and multivariate analysis
1988
Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis
1987
Prognostic value of estrogen and progesterone receptors in operable breast cancer
1987
An EORTC phase II study of mitoxantrone in solid tumors and lymphomas
1984
Topotecan (T) and cyclophosphamide (CY) in second line treatment of advanced ovarian cancer (AOC): a gineco phase II trial
2001
Renal Function and Alterations in Plasma Electrolyte Levels in Normocalcaemic and Hypercalcaemic Patients with Malignant Diseases, Given an Intravenous Infusion of Mithramycin
1974